The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy by Bjorkander, J, Spickett, G, Ericson, D, Engl, W, Eibl, M, Chapel, H

European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries. by Quinti, I, Pierdominici, M, Marziali, M, Giovannetti, A, Donnanno, S, Chapel, H, Bjorkander, J, Aiuti, F

Common variable immunodeficiency disorders: division into distinct clinical phenotypes. by Chapel, H, Lucas, M, Lee, M, Bjorkander, J, Webster, D, Grimbacher, B, Fieschi, C, Thon, V, Abedi, MR, Hammarstrom, L